Rappta Therapeutics Competitors and Similar CompaniesClear all
Infinity Pharmaceuticals's competitors and similar companies include Exelixis and TRACON Pharmaceuticals.
 Infinity Pharmaceuticals Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions. |  TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration. | ||
Founding Date | Founding Date 2000 | Founding Date 1994 | Founding Date 2006 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Alameda, US HQ | Locations San Diego, US HQ |
Employees | Employees 25 | Employees 1,14712% decrease | Employees 268% increase |
Valuation ($) | Valuation ($) 726.1 k | Valuation ($) 8.2 b | Valuation ($) 279.4 k |
Financial | |||
Revenue (est.) | Revenue (est.) $2.6m (FY, 2022) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $12m (FY, 2023) |
Net income | Net income ($44.4m) (FY, 2022) | Net income $782.6m (FY, 2025) | Net income ($3.6m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 106.6m | Total funding raised N/A | Total funding raised $ 41m |
For sources of this data, please see the company profile
View Company Profiles
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View companyTRACON Pharmaceuticals
HQ
San Diego, US
Employees
26↑ 8% increase
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
View company